Apple Watch Series 11, Apple Watch SE 3, and Apple Watch Ultra 3 are scheduled for global unveiling on September 9 alongside the iPhone 17 lineup. Series 11 is expected to be an iterative upgrade over Series 10, featuring flat sides, 42mm and 46mm sizes, an LTPO display, improved battery life, and Apple's S11 chip built on the S10/S9 architecture. Series 11 may add blood pressure monitoring limited to hypertension detection and alerts rather than systolic and diastolic readings. Series 11 is expected to adopt a MediaTek modem supporting 5G Reduced Capability (RedCap) to improve battery life. Ultra 3 will succeed Ultra 2; SE 3 will succeed SE 2.
Recent reports suggest that the Apple Watch Series 11 will only see iterative improvements over its predecessor, the Watch Series 10. In terms of design, it might come with flat sides, as seen on previous models, and might be offered in 42mm and 46mm size variants. It might also feature improved battery life and sport an LTPO display. It will reportedly be powered by Apple's S11 chip, built on the same architecture as the S10 and S9 chips,
However, it might also offer the blood pressure monitoring capabilities, which were earlier only offered with the Watch Ultra series smartwatches. The feature might not offer systolic and diastolic measurements. Instead, it will reportedly only monitor hypertension, while alerting the wearer of any detected symptoms. The Apple Watch Series 11 is expected to also feature a new MediaTek modem technology, abandoning the Intel models. This might enable the smartwatch model to offer 5G Reduced Capability (RedCap) support.
#apple-watch-series-11 #health-monitoring #mediatek-5g-redcap #apple-watch-ultra-3 #apple-watch-se-3
Collection
[
|
...
]